Sector: Pharmaceuticals & Biotechnology

Small Cap

Rekvina Laboratories Share Price

Q: What is the Market Capitalization of Rekvina Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 21 August 2026, the market cap for Rekvina Laboratories Ltd. is approximately ₹ 25.9 Cr.

Q: What are the PE and PB ratios for Rekvina Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Rekvina Laboratories Ltd. is -76.3, and the Price-to-Book (PB) ratio is -19.2.

Q: What is the 52-Week High and Low for Rekvina Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Rekvina Laboratories Ltd. shares was ₹ 46.65, and the lowest price was ₹ 6.75.

Q: Who are the major shareholders of Rekvina Laboratories Ltd.?

Significant shareholdings in Rekvina Laboratories Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Rekvina Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Rekvina Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines and Accretion Nutraveda for analysis and benchmarking.

VINRKLB

₹43.80

2.08(4.99%)

24th Aug 2026 | 3:04 PM

NSE :

Open Free Demat Account

Rekvina Laboratories Performance

Price Movement

N/A

₹41.00

₹43.80

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹43.80

Low₹41.00

Open at₹43.00

Prev Close₹41.72

Volumes4.85 K

Avg Price₹43.02

Lower Circuit₹41.61

Upper Circuit₹45.99

Historical Performance

3M High₹45.13

3M Low₹25.00

1 Yr High₹46.65

1 Yr Low₹6.75

3 Yr High₹46.65

3 Yr Low₹6.75

5 Yr High₹46.65

5 Yr Low₹3.80

Summary

As of 25-08-2026 03:50, Rekvina Laboratories Ltd. share price today is ₹0, with a change of ₹-41.72 (-100.00%) from the previous close of ₹41.72. The stock opened at ₹43 and traded between ₹41 and ₹43.8, with a total traded volume of 4853 shares. The company has a market capitalization of ₹25.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹46.65 and ₹6.75, respectively.

Rekvina Laboratories Ltd. valuation metrics include a P/E ratio of -76.3, and book value of ₹-19.20. Rekvina Laboratories Ltd. has reported revenue of ₹1.93 Cr and net profit of ₹-0.34 Cr.

Rekvina Laboratories Ltd. technical indicators include Day RSI at 78, Day MFI at 100, Day ADX at 46.12. Additional indicators include Commodity Channel Index (CCI) at 114.2 and Williams %R at -7.73. Momentum indicators show Day MACD at 2.62, Day MACD Signal Line at 0.93, DayATR at 1.72. Rate of Change indicators for Rekvina Laboratories Ltd. include ROC125 at 124.91 and ROC21 at 49.

Exponential moving averages include EMA5 at ₹40.6, EMA10 at ₹37.9, EMA12 at ₹37, EMA20 at ₹35, EMA26 at ₹34.4, EMA50 at ₹34.1, EMA100 at ₹32.5, EMA200 at ₹26.8. Simple moving averages include SMA5 at ₹41.1, SMA10 at ₹37.5, SMA20 at ₹31.8, SMA30 at ₹31.8, SMA50 at ₹34.1, SMA100 at ₹36.7, SMA150 at ₹30.4, SMA200 at ₹24.

Support levels for Rekvina Laboratories are placed at First Support ₹40.08, Second Support ₹38.44, Third Support ₹36.98. Resistance levels are seen at First Resistance ₹43.18, Second Resistance ₹44.64, Third Resistance ₹46.28. Rekvina Laboratories Ltd. shareholding pattern shows promoter holding at 41.3%, FII holding at 0%, DII holding at 0%, public holding at 58.7%.

Rekvina Laboratories Fundamentals

Market Cap

Low in industry

25.90 Cr.

PE Ratio (TTM)

Negative PE TTM

-76.30

Dividend Yield

Net Profit TTM

100% decr over last year

-0.34

Net Profit Growth

100% decr over last year

-0.34

PEG Ratio

Above industry Median

0.80

ROE

Operating Revenue TTM

1.93

Operating Revenue Growth

Book Value

Negative Price to Book

-19.20

MFI

MFI strongly Overbought

100

RSI

RSI Overbought

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

-19.20

Rekvina Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	0.67	0.72	0.35	0.20	0
Operating Expense	0.79	0.78	0.47	0.23	0.04
Operating Profit	-0.12	-0.06	-0.12	-0.03	-0.04
Depreciation	0	0	0	0	0
Interest	0	0	0	0	0
Tax	0	0	0	0	0
Net Profit	-0.12	-0.06	-0.12	-0.03	-0.04

Rekvina Laboratories Technicals

Rekvina Laboratories Ltd. EMA & SMA

₹43.80

1.80 (4.29%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹40.6

Day EMA10 ₹37.9

Day EMA12 ₹37

Day EMA20 ₹35

Day EMA26 ₹34.4

Day EMA50 ₹34.1

Day EMA100 ₹32.5

Day EMA200 ₹26.8

Rekvina Laboratories Support and Resistance

Resistance

First Resistance₹43.18

Second Resistance₹44.64

Third Resistance₹46.28

Support

First Support₹40.08

Second Support₹38.44

Third Support₹36.98

Technical Indicators

Day RSI78.00

Day MFI100.00

Day ADX46.12

Day Commodity Channel Index114.20

William-7.73

Day MACD2.62

Day MACD Signal Line0.93

Day ATR1.72

Day ROC125124.91

Day ROC2149.00

Rekvina Laboratories Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	41.3	41.3	41.3	41.3	41.3	41.3
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	58.7	58.7	58.7	58.7	58.7	58.7

Rekvina Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.75 K	1.75 K	100.00%
Week	2.77 K	2.83 K	98.22%
1 Month	1.59 K	1.63 K	97.69%
6 Month	3.61 K	3.62 K	99.83%

Rekvina Laboratories SWOT Analysis

Strengths16

Weakness9

Opportunity0

Threats1

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Rekvina Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Rekvina Laboratories Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Vivimed Labs Ltd.
Price (₹)	₹40.95	₹526.25	₹151.20	₹286	₹6.55
% Change	-0.05%	-2.70%	0.00%	0.00%	4.97%
Revenue TTM (₹ Cr)	-	₹526.28	-	-	₹69.99
Net Profit TTM (₹ Cr)	-	₹20.77	-	-	₹-176.47
PE TTM	9.60	115.10	10.20	40.90	-0.30
1 Year Return		37.97			524
ROCE	-	3.56	-	-	-56.37

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 296.40

+2.00%

AMANTA

Amanta Healthcare Ltd.

₹ 205.20

+4.81%

AHCL

Anlon Healthcare Ltd.

₹ 15.46

+8.26%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 93.30

-2.81%

APL

Asston Pharmaceuticals Ltd.

₹ 86.00

+1.74%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 518.70

-3.29%

ASTONEALAB

Astonea Labs Ltd.

₹ 278.00

-0.36%

AMWILL

Amwill Health Care Ltd.

₹ 43.50

+0.00%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 100.52

+4.99%

SHELTER

Shelter Pharma Ltd.

₹ 34.00

+6.25%

TLL

Trident Lifeline Ltd.

₹ 272.60

-3.49%

DPL

Dipna Pharmachem Ltd.

₹ 5.90

-7.81%

ACHYUT

Achyut Healthcare Ltd.

₹ 7.00

+0.00%

SIGACHI

Sigachi Industries Ltd.

₹ 30.45

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 988.00

-0.56%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-2.14%

CHCL

Cian Healthcare Ltd.

₹ 10.02

+4.92%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 628.00

+1.80%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.42

+7.69%

ZIMLAB

Zim Laboratories Ltd.

₹ 124.16

-0.70%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1469.95

+6.29%

MEDICO

Medico Remedies Ltd.

₹ 42.09

-1.31%

SGRL

Shree Ganesh Remedies Ltd.

₹ 516.50

+1.99%

FAQ's on VINRKLB

What is the Market Capitalization of Rekvina Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 21 August 2026, the market cap for Rekvina Laboratories Ltd. is approximately ₹ 25.9 Cr.

What are the PE and PB ratios for Rekvina Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Rekvina Laboratories Ltd. is -76.3, and the Price-to-Book (PB) ratio is -19.2.

What is the 52-Week High and Low for Rekvina Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Rekvina Laboratories Ltd. shares was ₹ 46.65, and the lowest price was ₹ 6.75.

Who are the major shareholders of Rekvina Laboratories Ltd.?

Significant shareholdings in Rekvina Laboratories Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Rekvina Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Rekvina Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines and Accretion Nutraveda for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy